• Thurs news: Novo Nordisk’s port strike distribution plan. Arcus/AZ renal cancer trial. Lilly weight loss drugs no longer in shortage. Difficulties of a CVS breakup. Google and Biontech AI lab assistants. See more on our front page

Thanks for the promised call back for the interview for Humira.

Mr. Smug Humira rep,
You need to get a clue bro. Your ass is hangin out too when it comes to job security. Your competition stiffens daily and its going to be all about price soon.
Humira is run like a preschool with micromanagement and infantile approaches. Got anyone covering the same providers as you? Well, that duplication will be soon ending. It is inefficient and nothing more then an irritant to the offices of today. The pharma model is changing drastically. Humira is no big shit anymore. It is in a crowded market and Pfizer is licking their chops with the oral version.
Don't be so smug. You may be safe for this year, but I still wouldn't bet on it.
In the meantime, enjoy the pressure cooker environment. And keep those pizzas delivered on time and nice and warm for the cows that you serve. LMFAO!!

Ditto for Androgel. These "saviors" are extremely shakey and the work environment sux. Wouldnt want to be counting on either drugs sales stability to pay long term financial obligations. Suggest you rent.
 








Similar threads

Replies
1
Views
808
AbbVie
anonymous
Replies
156
Views
17K
AbbVie
Anonymous
Replies
11
Views
3K
AbbVie
Anonymous
Replies
42
Views
6K
AbbVie
Anonymous
Replies
16
Views
4K
AbbVie
Anonymous